SCHEMBL14925941

SCHEMBL14925941

CCC1(C)C=Cc2cc(C(C)C)ccc2O1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.50
PTGS2 P35354 1/20 0.50
XDH P47989 1/20 0.50
HIF1A Q16665 8/20 0.39
EPAS1 Q99814 8/20 0.39
BACE1 P56817 1/20 0.34
KDM4E B2RXH2 1/20 0.31
NPC1 O15118 1/20 0.31
CA12 O43570 1/20 0.31
ALDH1A1 P00352 1/20 0.31
CA1 P00915 1/20 0.31
TP53 P04637 1/20 0.31
POLB P06746 1/20 0.31
MAPT P10636 1/20 0.31
HPGD P15428 1/20 0.31
CA7 P43166 1/20 0.31
RAB9A P51151 1/20 0.31
SMN1; SMN2 Q16637 1/20 0.31
CA9 Q16790 1/20 0.31
CA13 Q8N1Q1 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9582367 0.81 HIF1A (0.45) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL14930314 0.80 PTGS1 (0.54) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL4800628 0.78 PTGS1 (0.53) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL2562052 0.76 XDH (0.50) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL2558890 0.74 PTGS1 (0.46) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL14178674 0.69 HIF1A (0.48) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL2557901 0.69 HIF1A (0.52) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL4801084 0.69 PTGS1 (0.42) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL9034234 0.69 HIF1A (0.43) PTGS1PTGS2XDHHIF1AEPAS1
SCHEMBL5499257 0.67 ALDH1A1 (0.42) PTGS1PTGS2XDHHIF1AEPAS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9062072-B2 Inhibitors of HIF and angiogenesis EMORY UNIVERSITY (US) 2015-06-23 US disclosed
US-20130116275-A1 INHIBITORS OF HIF AND ANGIOGENESIS GEORGIA STATE UNIVERSITY RESEARCH FOUNDATION (US) 2013-05-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130116275-A1 INHIBITORS OF HIF AND ANGIOGENESIS HIF1AN, HIF1A, EGLN2 PTGS1 33/4885PTGS2 48/4885XDH 903/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.